[HTML][HTML] Reassessing vascular endothelial growth factor (VEGF) in anti-angiogenic cancer therapy

TC Elebiyo, D Rotimi, IO Evbuomwan… - Cancer Treatment and …, 2022 - Elsevier
Vascularization is fundamental to the growth and spread of tumor cells to distant sites. As a
consequence, angiogenesis, the sprouting of new blood vessels from existing ones, is a …

[HTML][HTML] Communication in the cancer microenvironment as a target for therapeutic interventions

A Dominiak, B Chełstowska, W Olejarz, G Nowicka - Cancers, 2020 - mdpi.com
The tumor microenvironment (TME) is a complex system composed of multiple cells, such as
non-cancerous fibroblasts, adipocytes, immune and vascular cells, as well as signal …

Fucoidan/hyaluronic acid cross-linked zein nanoparticles loaded with fisetin as a novel targeted nanotherapy for oral cancer

MA Moustafa, WM El-Refaie, YSR Elnaggar… - International Journal of …, 2023 - Elsevier
Fisetin (FS) is an anticancer drug having potential role in oral tumors management.
However, its clinical application is limited due to its hydrophobicity and instability. Bioactive …

Vascular mimicry: Triggers, molecular interactions and in vivo models

SL Wechman, L Emdad, D Sarkar, SK Das… - Advances in cancer …, 2020 - Elsevier
Vascular mimicry is induced by a wide array of genes with functions related to cancer
stemness, hypoxia, angiogenesis and autophagy. Vascular mimicry competent (VM …

[HTML][HTML] Systemic Interleukins' profile in early and advanced colorectal cancer

P Czajka-Francuz, S Cisoń-Jurek, A Czajka… - International journal of …, 2021 - mdpi.com
Tumor microenvironment (TME) is characterized by mutual interactions of the tumor, stromal
and immune cells. Early and advanced colorectal tumors differ in structure and present …

[HTML][HTML] Synthesis, in silico study, and anti-cancer activity of thiosemicarbazone derivatives

BZ Sibuh, PK Gupta, P Taneja, S Khanna, P Sarkar… - Biomedicines, 2021 - mdpi.com
Thiosemicarbazones are known for their biological and pharmacological activities. In this
study, we have synthesized and characterized 3-Methoxybenzaldehyde thiosemicarbazone …

[HTML][HTML] Case report: a case of pituitary carcinoma treated with sequential dual immunotherapy and vascular endothelial growth factor inhibition therapy

LS Lamb, HW Sim, AI McCormack - Frontiers in Endocrinology, 2020 - frontiersin.org
Aggressive pituitary tumors (APTs) are associated with significant morbidity and mortality,
and effective treatment options are limited. Immune checkpoint inhibitors (ICIs) have …

[HTML][HTML] Metamorphic effect of angiogenic switch in tumor development: conundrum of tumor angiogenesis toward progression and metastatic potential

DL Moshe, L Baghaie, F Leroy, E Skapinker… - Biomedicines, 2023 - mdpi.com
Our understanding of angiogenesis has significantly expanded over the past five decades.
More recently, research has focused on this process at a more molecular level, looking at it …

Emerging trends in immunotoxin targeting cancer stem cells

BZ Sibuh, R Gahtori, N Al-Dayan, K Pant, BF Far… - Toxicology in Vitro, 2022 - Elsevier
Cancer stem cells (CSCs) are self-renewing multipotent cells that play a vital role in the
development of cancer drug resistance conditions. Various therapies like conventional …

Nanocarrier centered therapeutic approaches: Recent developments with insight towards the future in the management of lung cancer

JD Vanza, RB Patel, MR Patel - Journal of Drug Delivery Science and …, 2020 - Elsevier
At present, drug delivery strategies for minimizing unwanted toxicity to healthy cells and
improving the therapeutic efficacy have gained greater momentum, especially for lung …